About Mahkota Medical Centre
Mahkota Medical Centre, one of the largest private hospitals in Southern Peninsular Malaysia, is a multi-disciplinary private hospital located in the heart of Melaka, a UNESCO world heritage site.
Over 5 million visits
since 1994
300,000 patients
treated per year
120 consultants
ready to serve you
12,500 surgeries
performed annually
Highlights
Continued development to provide you with the finest care
![[object Object]'s image](https://cdn.sanity.io/images/jcgorcur/production/5998c4b8a28805c536bf8594b88140bd3303f205-6000x4000.jpg?w=96&auto=format)
![[object Object]'s image](https://cdn.sanity.io/images/jcgorcur/production/48c295e8ff0a643d399f7476221f95682a260d29-6000x3376.jpg?w=96&auto=format)
![[object Object]'s image](https://cdn.sanity.io/images/jcgorcur/production/f4a046858d8eb84267787d59b30086e800d91715-900x600.jpg?w=96&auto=format)
Our paramount commitment is to ensure superior patient outcomes and satisfaction.
Accreditation and awards
Mahkota Medical Centre (MMC) is the first JCI-accredited hospital in Melaka since 2020. MMC has been re-accredited for another 3 years, from 2023 to 2026 by JCI, the gold standard for healthcare quality and patient safety.
Other accreditations & awards
The GlobalHealth Asia-Pacific Awards – 2023 Medical Tourism Hospital of the Year in Asia Pacific
Mahkota Medical Centre (MMC) has been awarded for two consecutive years by GlobalHealth Asia-Pacific with the title of Medical Tourism Hospital of the Year in Asia Pacific, reflecting our commitment to providing high-quality healthcare to our international patients. We are committed to providing our patients with the best possible care, and we will continue to strive to improve our services.
Joint Commission International (JCI)
Mahkota Medical Centre (MMC) is the first JCI-accredited hospital in Melaka since 2020. MMC has been re-accredited for another 3 years, from 2023 to 2026 by JCI, the gold standard for healthcare quality and patient safety. This esteemed recognition has been achieved following a thorough and demanding evaluation of the facility’s performance while also meeting stringent requirements for patient safety and quality of care. The JCI accreditation is an attestation to the high standards of medical care within Mahkota Medical Centre, providing patients with the assurance that they will receive exceptional medical treatment.
JCI Clinical Care Programme Certification (CCPC) for Breast Cancer
Mahkota Medical Centre is the first hospital in Malaysia to be awarded the CCPC from JCI for Breast Cancer. This prestigious certification recognises the hospital’s outstanding care provided to patients with breast cancer, and the commitment to meeting high standards of compliance and safety. The CCPC serves as evidence that Mahkota Medical Centre offers a practical, evidence-based, and holistic approach to the diagnosis, treatment, care, and support of breast cancer patients.
Malaysian Society for Quality in Health (MSQH) Accreditation – 6th Edition
Mahkota Medical Centre successfully received another full four-year accreditation for MSQH 6th Edition in 2022. MSQH is dedicated to improving the quality of the nation’s health care through voluntary accreditation. The Malaysian Hospital Accreditation Standards are intended to stimulate continuous, systematic improvement in an organisation’s performance and the outcomes of care. Granted the full 4 years of MSQH accreditation since 2014 .
MS ISO 15189 Accreditation
The Department of Standards Malaysia (STANDARD MALAYSIA) has granted MMC laboratory a three (3) year accreditation in the fields of Medical Testing: Chemical Pathology and Haematology; namely MS ISO 15189 “Medical Laboratories – Particular requirements for Quality and Competence”. Granted the MS ISO 15189 accreditation since 2011.
The GlobalHealth Asia-Pacific Awards – 2022 Medical Tourism Hospital of the Year in Asia Pacific
Mahkota Medical Centre has been awarded by GlobalHealth Asia-Pacific the title of Medical Tourism Hospital of the Year in Asia Pacific for its efforts to provide top-notch facilities and services to foreign patients at every point of contact.
The GlobalHealth Asia-Pacific Award – 2021 Oncology (Surgical) Service Provider of the Year in the Asia-Pacific
The GlobalHealth Asia-Pacific has awarded Mahkota Medical Centre for consistently maintaining high standards in delivering quality care and going the extra mile to assist cancer patients at every touchpoint.
The GlobalHealth Asia-Pacific Award – 2020 Diabetes Service Provider of the Year in Asia Pacific
The GlobalHealth Asia-Pacific has awarded Mahkota Medical Centre for its efforts in providing excellent diabetes services to patients at every stage and in every interaction.
2018 Frost & Sullivan Malaysia Medical Tourism Hospital Customer Value Leadership Award
Frost & Sullivan has recognised Mahkota Medical Centre for Medical Tourism Hospital Customer Value Leadership Award. The criteria for the Customer Value Leadership Award is mainly guided by Customer Impact and Business Impact criteria, for example, customer service, its brand, its processes, its services to make customers feel valued and confident in the company’s services.
The Global Health & Travel Award – 2017 & 2018 Fertility Service Provider of the Year
For 2 consecutive years, The Global Health & Travel (GHT) Award recognized Mahkota Medical Centre as the Fertility Service Provider of the Year that has pushed boundaries of delighting their customers at every stage and in every interaction. The program measures customer sentiment across various touch points and throughout the customer lifecycle in various industries. In surveying the customer pool, their panel of esteemed healthcare industry judges and analyzing assessments by the GHT editorial team, the GHT Award aims to be an effective measurement tool for business to benchmark themselves against industry standards and their peers.
2015 Frost & Sullivan Malaysia Medical Tourism Hospital of the Year
Frost & Sullivan awarded Mahkota Medical Centre with the 2015 Malaysia Excellence Awards for the Medical Tourism Hospital of the Year. This award acknowledges companies that have pushed the boundaries of excellence – rising above the competition and demonstrating outstanding performance in Malaysia. Award recipients are identified based on in-depth interviews, analysis, and extensive secondary research conducted by Frost & Sullivan’s analysts and after studying their revenues, market share, capabilities, and overall contribution to the industry in order to identify best practices.
The BrandLaureate SMEs Master Award 2013 for Best Hospital Brand
Mahkota Medical Centre was awarded the prestigious Brand Laureate SMEs Master Award 2013 by the Asia Pacific Brand Foundation (APBF) for the category of Best Brand in Wellness Healthcare – Hospital.
HMI Group
One of the fastest growing healthcare providers in Southeast Asia
Founded in 1998, a growing regional private healthcare provider with presence in Singapore, Malaysia and Indonesia.
Our sister hospital
Regency Specialist Hospital
Regency is a multi-disciplinary and fast-growing private hospital in Malaysia with 218 bed capacity serving around 170,000 patients annually.
Visit website
HMI Singapore
StarMed Specialist Centre
Established in 2018, StarMed is Singapore’s latest one-stop private ambulatory care centre.
Visit websiteOur GP clinics
One Care Medical Clinics
25 One Care Medical Clinics providing timely, affordable, and professional GP healthcare.
Visit websiteOur eye specialist care
Eagle Eye Centre
Founded in 2006, Eagle Eye Centre is the largest private ophthalmology chain in Singapore.
Visit websiteMahkota Medical Milestones
Significant moments that marked our growth
Founded on 30 September 1994. The hospital was launched by YB Dato’ Lee Kim Sai, former Minister of Health Malaysia. It started out with 84 beds.
Launched the Cardiac Catheterisation Laboratory on 7 January by Datuk Gan Boon Leong.
Radiotherapy & Oncology Department started to operate on 22 April.
Launched the Heart Centre on 6 June by Datuk Chua Jui Meng, former Minister of Health Malaysia.
Launched the Renal (Haemodialysis) Centre on 2 August by Datin Seri Dr Wan Azizah binti Dato’ Dr Wan Ismail.
In-Vitro Fertilisation (IVF) Centre commenced its service in July 1997 and launched by Datuk Seri Abu Zahar bin Hj. Isnin on 6 September 1998.
First venture into medical tourism in Sumatera, Indonesia.
Opened the first representative office in Pekan Baru, Indonesia. The role of the representative office is to provide care options, information, and services to people across the region.
The first live birth case of baby conceived through Intracytoplasmic Sperm Injection (ICSI) using frozen sperm and embryos that were transferred on day-three extended culture.
Awarded the “Melaka Tourism Award 2005” for Best Health Tourism Product by Tourism Malaysia and the Melaka State Government.
Awarded the “Export Excellence Award (Services) 2007” by the Ministry of International Trade and Industry, Malaysia.
Received accreditation from Malaysian Society for Quality in Health (MSQH) for a period of three years.
Expanded to 235 beds.
Opened a total of eight representative offices in Indonesia and Cambodia.
Increased beds to 288, became one of the largest private hospital in Southern Peninsular Malaysia. Celebration of 2.5 millionth patient.
Mahkota’s Laboratory awarded MS ISO 15189 by the Department of Standards Malaysia. We are among the first hospital-based laboratory to win this award in Southern Malaysia.
Organize a laparoscopic workshop that includes live surgery demonstration from the Operating Theatre.
A Neuro Diagnostic Laboratory was set up in January for diagnosis of nervous system disorder.
Introduced the Aesthetic & Laser Services and Diabetes Unit.
Launched seven Centres of Excellence: Bone & Joint Replacement Centre, Cancer Centre, Heart Centre, Men’s Health Centre, Neurological & Stroke Centre, Wellness Centre and Woman & Child Centre.
First kidney transplant performed at Mahkota.
Received MHTC Award for Outstanding Achievement 2012. The highest number of healthcare travelers and highest revenue for healthcare travelers (Southern region).
Awarded a full 4-year accreditation (4th Edition) from MSQH.
Launched three more Centres of Excellence: Diabetes Centre, Emergency & Trauma Centre and Liver & Gastro Centre.
Won Frost & Sullivan Medical Tourism Hospital of the Year.
PET-CT Scan officiated by Minister of Health Datuk Seri S. Subramaniam on 20 Jul 2017, Mahkota is among the first hospital in Melaka and Negeri Sembilan to offer this service.
Among the first private hospital in Melaka to have Endoscopic Ultrasound (EUS).
Awarded Global Health & Travel Awards 2017 – Fertility Service Provider of the Year.
Rebranding of Mahkota with a refreshed new logo and renewed brand commitment.
Awarded a full 4-year accreditation (5th Edition) from MSQH.
Awarded Global Health & Travel Awards 2018 – Fertility Service Provider of the Year.
Conferred Malaysia Medical Tourism Hospital Customer Value Leadership Award by Frost & Sullivan.
Tomotherapy Radixact (X7) was officiated by Deputy Minister of Health, YB Dr Lee Boon Chye on 29 October. We are the first hospital to install and offer Radixact X7 treatment in Malaysia. With the introduction of this new cancer treatment, Mahkota’s Cancer Centre is now one of the most comprehensive cancer centre in Malaysia.
In conjunction with Mahkota’s 25th anniversary and its sister hospital, Regency Specialist Hospital’s 10th anniversary, both hospital organised the largest participation in CPR simultaneously at Melaka & Johor on 19 Oct and achieved a record-breaking 10,139 participants.
Awarded Joint Commission International (JCI) accreditation, became the first JCI-accredited hospital in Melaka. JCI is the international gold standard to ensure the best healthcare practices in quality and patient safety.
Awarded GlobalHealth Asia-Pacific Award – 2020 Diabetes Service Provider of the Year in Asia Pacific.
Awarded GlobalHealth Asia-Pacific Award – 2021 Oncology (Surgical) Service Provider of the Year in Asia Pacific.
Launched the first ultrasound based High Intensity Focus Ultrasound (HIFU) Centre in Malaysia. This technology offers non-invasive treatment for uterine fibroids and adenomyosis.
Entered into a 5-year strategic partnership with Siemens Healthineers in April. Artis Zee Multipurpose C-arm Fluoroscopy and CT Scan Siemens Somatom Drive Dual Source were installed and this partnership will improve treatment and patient care options for Melaka in both cancer and cardiovascular disease through further development of its Centre of Excellence (COE).
Collaborated with the Melaka State Health Department and ProtectHealth Corporation to facilitate the National COVID-19 Immunisation Programme in reaching the inoculation targets. Completed vaccination for a total of 9,924 people.
Due to the pandemic, Dual Source CT Scanner has been virtually launched by Mr Stanley Lam, CEO and Dr. Ng Seng Man, Head of Radiology Department on 28 April 2022. With this scanner, we aim to provide a technology that will ultimately provide the best scanning experience for our patients.
Mahkota Medical Centre has been awarded the GlobalHealth Asia-Pacific Medical Tourism Hospital of the Year in Asia Pacific for its efforts to provide top-notch facilities and services to international patients at every point of contact.
Mahkota Medical Centre successfully received another full four-year accreditation for MSQH 6th Edition in 2022. MSQH is dedicated to improving the quality of the nation’s health care through voluntary accreditation. The Malaysian Hospital Accreditation Standards are intended to stimulate continuous, systematic improvement in an organisation’s performance and the outcomes of care.
Mahkota Medical Centre is proud to be named as one of the four finalists in the prestigious Flagship Medical Tourism Hospital Programme. This initiative, spearheaded by the Malaysian Healthcare Travel Council and endorsed by the Malaysian government and the Ministry of Health, aims to establish Malaysia as a globally renowned icon for healthcare travel.
Mahkota Medical Centre (MMC) is the first Joint Commission International, JCI-accredited hospital in Melaka since 2019. MMC has been re-accredited for another 3 years, from 2023 to 2026 by JCI, the gold standard for healthcare quality and patient safety. This esteemed recognition has been achieved following a thorough and demanding evaluation of the facility’s performance while also meeting stringent requirements for patient safety and quality of care. The JCI accreditation is an attestation to the high standards of medical care within MMC, providing patients with the assurance that they will receive exceptional medical treatment.
Mahkota Medical Centre reaches an important milestone yet again as the hospital receives the prestigious Global Health Asia-Pacific award for Medical Tourism Hospital of the Year in Asia Pacific 2023.
Receiving the award for two consecutive years reflects our commitment to providing high-quality healthcare to our international patients. We are committed to providing our patients with the best possible care, and we will continue to strive to improve our services.
Mahkota Medical Centre is the first hospital in Malaysia to be awarded the Breast Cancer Clinical Care Programme Certification (CCPC) from JCI. This prestigious certification recognises the hospital’s outstanding care provided to patients with breast cancer, and the commitment to meeting high standards of compliance and safety. The CCPC serves as evidence that MMC offers a practical, evidence-based, and holistic approach to the diagnosis, treatment, care, and support of breast cancer patients. Click here for more information.
Patient care at Mahkota Medical
Compassion
Understanding our patients and responding with genuine care and concern
Competence
Knowledge, skills and commitment to act efficiently in your best interest
Collaboration
Professionals working together seamlessly to best serve your health needs
Community
Building a strong and healthy community through first-class health care